Gary D. Probst

1.3k total citations
17 papers, 545 citations indexed

About

Gary D. Probst is a scholar working on Molecular Biology, Organic Chemistry and Physiology. According to data from OpenAlex, Gary D. Probst has authored 17 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Physiology. Recurrent topics in Gary D. Probst's work include Alzheimer's disease research and treatments (4 papers), Chemical Synthesis and Analysis (3 papers) and Computational Drug Discovery Methods (3 papers). Gary D. Probst is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Chemical Synthesis and Analysis (3 papers) and Computational Drug Discovery Methods (3 papers). Gary D. Probst collaborates with scholars based in United States. Gary D. Probst's co-authors include Barry M. Trost, Ying‐zi Xu, Simeon Bowers, Gergely Tóth, Hanbiao Yang, Andrei W. Konradi, Xiang‐Dong Fu, Fulong Li, Tracy Tang and Shenghong Ma and has published in prestigious journals such as Journal of the American Chemical Society, Nature Communications and PLoS ONE.

In The Last Decade

Gary D. Probst

17 papers receiving 535 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gary D. Probst United States 11 226 188 77 76 75 17 545
Ryan MacArthur United States 16 307 1.4× 69 0.4× 90 1.2× 40 0.5× 43 0.6× 24 562
Diane Allegro France 15 298 1.3× 242 1.3× 27 0.4× 91 1.2× 37 0.5× 25 543
Hachemi Kadri United Kingdom 12 303 1.3× 415 2.2× 22 0.3× 20 0.3× 30 0.4× 16 807
Duncan S. Holmes United Kingdom 16 426 1.9× 339 1.8× 48 0.6× 44 0.6× 71 0.9× 39 692
Helen Browne United Kingdom 6 351 1.6× 349 1.9× 49 0.6× 76 1.0× 63 0.8× 8 742
Simeon Bowers United States 10 194 0.9× 160 0.9× 29 0.4× 12 0.2× 49 0.7× 12 343
Li‐Hsing Chen United States 11 343 1.5× 157 0.8× 106 1.4× 22 0.3× 27 0.4× 12 499
Chander Singh Digwal India 14 292 1.3× 317 1.7× 41 0.5× 62 0.8× 45 0.6× 26 582
Steven R. Schow United States 17 439 1.9× 390 2.1× 22 0.3× 72 0.9× 66 0.9× 41 918
Mariola Andrzejewska Poland 7 323 1.4× 318 1.7× 64 0.8× 33 0.4× 19 0.3× 12 680

Countries citing papers authored by Gary D. Probst

Since Specialization
Citations

This map shows the geographic impact of Gary D. Probst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary D. Probst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary D. Probst more than expected).

Fields of papers citing papers by Gary D. Probst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary D. Probst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary D. Probst. The network helps show where Gary D. Probst may publish in the future.

Co-authorship network of co-authors of Gary D. Probst

This figure shows the co-authorship network connecting the top 25 collaborators of Gary D. Probst. A scholar is included among the top collaborators of Gary D. Probst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary D. Probst. Gary D. Probst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ma, Shenghong, Tracy Tang, Gary D. Probst, et al.. (2022). Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer. Nature Communications. 13(1). 1061–1061. 93 indexed citations
2.
Peine, Kevin J., Mireia Guerau‐de‐Arellano, Priscilla Ming Yi Lee, et al.. (2014). Treatment of Experimental Autoimmune Encephalomyelitis by Codelivery of Disease Associated Peptide and Dexamethasone in Acetalated Dextran Microparticles. Molecular Pharmaceutics. 11(3). 828–835. 59 indexed citations
3.
Mondal, Kalyani, Karin Regnström, Robin Barbour, et al.. (2013). Thermodynamic and kinetic characterization of hydroxyethylamine β-secretase-1 inhibitors. Biochemical and Biophysical Research Communications. 441(2). 291–296. 5 indexed citations
4.
Garofalo, Albert W., Marc Adler, Danielle L. Aubele, et al.. (2013). Discovery of 4-alkylamino-7-aryl-3-cyanoquinoline LRRK2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(7). 1974–1977. 23 indexed citations
5.
Franzini, Maurizio, Marc Adler, Danielle L. Aubele, et al.. (2013). Triazolopyridazine LRRK2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(7). 1967–1973. 24 indexed citations
6.
Bowers, Simeon, Ying‐zi Xu, Shendong Yuan, et al.. (2013). Structure-based design of novel dihydroisoquinoline BACE-1 inhibitors that do not engage the catalytic aspartates. Bioorganic & Medicinal Chemistry Letters. 23(7). 2181–2186. 10 indexed citations
7.
Probst, Gary D. & Ying‐zi Xu. (2012). Small-molecule BACE1 inhibitors: a patent literature review (2006 – 2011). Expert Opinion on Therapeutic Patents. 22(5). 511–540. 60 indexed citations
8.
Garofalo, Albert W., Marc Adler, Danielle L. Aubele, et al.. (2012). Novel cinnoline-based inhibitors of LRRK2 kinase activity. Bioorganic & Medicinal Chemistry Letters. 23(1). 71–74. 30 indexed citations
9.
Justice, Sheryl S., Birong Li, Jennifer S. Downey, et al.. (2012). Aberrant Community Architecture and Attenuated Persistence of Uropathogenic Escherichia coli in the Absence of Individual IHF Subunits. PLoS ONE. 7(10). e48349–e48349. 21 indexed citations
10.
Ness, Daniel, Manuel Buttini, William H. Jordan, et al.. (2011). P4‐022: Neuropathology associated with administration of a nonselective beta secretase (BACE) and cathepsin D inhibitor in Mdr 1a/b knockout mice. Alzheimer s & Dementia. 7(4S_Part_20). 1 indexed citations
11.
12.
Bowers, Simeon, Gary D. Probst, Anh P. Truong, et al.. (2009). N-Bridged bicyclic sulfonamides as inhibitors of γ-secretase. Bioorganic & Medicinal Chemistry Letters. 19(24). 6952–6956. 9 indexed citations
13.
Tóth, Gergely, et al.. (2007). The Role and Significance of Unconventional Hydrogen Bonds in Small Molecule Recognition by Biological Receptors of Pharmaceutical Relevance. Current Pharmaceutical Design. 13(34). 3476–3493. 58 indexed citations
14.
Trost, Barry M., Hanbiao Yang, & Gary D. Probst. (2003). A Formal Synthesis of (−)-Mycalamide A. Journal of the American Chemical Society. 126(1). 48–49. 43 indexed citations
15.
Kasibhatla, Srinivas Rao, Brett C. Bookser, Gary D. Probst, James R. Appleman, & Mark D. Erion. (2000). AMP Deaminase Inhibitors. 3. SAR of 3-(Carboxyarylalkyl)coformycin Aglycon Analogues. Journal of Medicinal Chemistry. 43(8). 1508–1518. 22 indexed citations
16.
Kasibhatla, Srinivas Rao, Brett C. Bookser, James R. Appleman, et al.. (1998). Design, Synthesis, and Structure-Activity Relationships of the First Highly Potent, Selective, and Bio Available Adenosine 5′-Monophosphate Deaminase Inhibitors. Advances in experimental medicine and biology. 849–852. 1 indexed citations
17.
Trost, Barry M., et al.. (1998). Ruthenium-Catalyzed Alder Ene Type Reactions. A Formal Synthesis of Alternaric Acid. Journal of the American Chemical Society. 120(36). 9228–9236. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryan MacArthur Breakdown of academic impact, for papers by Diane Allegro Breakdown of academic impact, for papers by Hachemi Kadri Breakdown of academic impact, for papers by Duncan S. Holmes Breakdown of academic impact, for papers by Helen Browne Breakdown of academic impact, for papers by Simeon Bowers Breakdown of academic impact, for papers by Li‐Hsing Chen Breakdown of academic impact, for papers by Chander Singh Digwal Breakdown of academic impact, for papers by Steven R. Schow Breakdown of academic impact, for papers by Mariola Andrzejewska
Rankless by CCL
2026